Osheru, founded by Drs. Patricia and Knute Buehler, develops innovative medical devices for skin surgery. Its lead product, Ziplyft, is designed to address challenges of conventional blepharoplasty by reducing downtime and lowering risks such as wound dehiscence and asymmetry through a proprietary design. The company plans commercialization of Ziplyft in 2025 and aims to serve ophthalmologists, oculoplastic surgeons, facial plastic surgeons, and other specialties treating excess skin. Osheru highlights a sizable market opportunity, citing about 1.7 million eyelid surgeries worldwide in 2023 (a 24% increase vs. 2022) and growing demand for less‑invasive alternatives. To support advancement toward market entry, the company completed a $4.7 million funding round. Osheru also appointed John Garland as chief commercial officer to lead commercialization efforts.

Total raised

$5M

Funding rounds

1

Latest round

Seed

Latest activity

Jul 2024